Concord Biotech has incorporated wholly owned subsidiary company namely ‘Concord Lifegen’. The newly incorporated entity belongs to Biopharmaceutical Industry. The wholly owned subsidiary company is incorporated to manage the marketing, sales, and distribution of pharmaceutical products. Its primary objectives include executing targeted sales strategies, ensuring regulatory compliance across domestic and international markets, handling logistics and customer support, and maintaining transparent reporting to the holding company.
Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
